{"nct_id":"NCT01241760","title":"VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection","status":"COMPLETED","status_verified_date":"2014-05","start_date":"2010-12","start_date_type":null,"primary_completion_date":"2012-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}